Share

Nuveen's Brian Nick on biotech surge over Covid-19 drug test optimism

Brian Nick, Nuveen Chief Investment Strategist, joins "Closing Bell" to discuss the state of the markets.
02:30
Fri, Apr 17 20203:57 PM EDT